A technology company that searches and analyzes natural immune systems to find antibodies.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about AbCellera Biologics Inc. in the last 30 days yet.
The 1 sources with the most insights about AbCellera Biologics Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Mentioned as one of the heavily shorted, smaller-cap stocks that saw significant gains due to a 'risk-on' appetite and speculative fervor in the market.
Mentioned as one of the heavily shorted, smaller-cap stocks that saw significant gains due to a 'risk-on' appetite and speculative fervor in the market.
Other assets that creators frequently mention in the same content as AbCellera Biologics Inc..
The most active sources covering AbCellera Biologics Inc. (ABCL) on Kazuha are @amitinvesting. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about AbCellera Biologics Inc. (ABCL) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering AbCellera Biologics Inc. (ABCL) most frequently also discuss BITF, SBET, RXRX, SQ, GRAB. See the "Discussed alongside" section above for full asset pages.